Humanetics Corporation

company

About

clinical stage pharmaceutical company.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$5.40M
Industries
Biotechnology,Clinical Trials,Medical,Pharmaceutical
Founded date
Jan 1, 1988
Number Of Employee
11 - 50
Operating Status
Active

Humanetics is a privately held, clinical stage pharmaceutical company located in the Minneapolis metropolitan area. The Company was founded in 1988 and is engaged in developing and commercializing products to enhance human health and wellbeing. Humanetics entered the field of radiation modulators in 2003, through a cooperative research program with the Armed Forces Radiobiology Research Institute (AFRRI). Humanetics began working with AFRRI to test an array of drug candidates using their highly developed capabilities. From this program, BIO 300 emerged as a lead candidate and the underlying technology was in-licensed from AFRRI to Humanetics. In the ensuing years, the Company has progressed this program into multiple clinical uses with a primary focus on improving treatment of solid tumor cancers.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$5.40M
Humanetics Corporation has raised a total of $5.40M in funding over 2 rounds. Their latest funding was raised on Jun 2, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 2, 2021 Grant 1 Regenerative Medicine Minnesota Detail
Apr 12, 2018 Grant $5.40M 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Humanetics Corporation is funded by 2 investors. Regenerative Medicine Minnesota and National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
Regenerative Medicine Minnesota Yes Grant
National Institutes of Health Yes Grant